Additionally, a higher percentage of ICOS+ T cells in peripheral blood may serve as a marker for good prognosis in colorectal cancer [35], whereas lower ICOS expression is linked to a poorer prognosis in oral squamous cell carcinoma [36]. This evidence concerns the gene ICOS and colorectal cancer.